Date Title
2025-02-14 World ADC US 2025
2025-02-14 World ADC Asia 2025
2025-01-14 Week 2, January 2025: Antibodies X PROTACs
2025-01-14 Antibody-Drug Conjugates: Transforming the Biopharma Landscape
2025-01-03 15th Annual World ADC – London 2025
2024-11-19 Antibody-Drug Conjugates: Microtubule Inhibitors, DNA Binders, and Topoisomerase Inhibitors
2024-10-28 What is ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity)?
2024-10-24 What are Antibody-Drug Conjugates?
2024-10-22 Week 4, October 2024: Further than ADCs?
2024-10-22 The Evolution of Antibody-Drug Conjugates (ADCs) in Cancer Therapy
2024-10-19 Antibody-Drug Conjugates (ADCs) and Drug–Antibody Ratio (DAR)
2024-10-08 Week 2, October 2024: ADCs in Regulatory Review
2024-10-06 Antibody-Drug Conjugates and Immune Checkpoint Inhibitors in Cancer Treatment
2024-09-26 What is Antibody Drug Development?
2024-09-13 What are Innovative Antibody Formats?
2024-09-06 Antibody Effector Functions
2024-08-26 Understanding the Difference Between ADC Biosimilars and ADC Isotypes
2024-08-20 Precision In Vivo Research: How ADCs Make the Difference
2024-08-13 Week 2, August 2024: Hepatitis B Virus (HBV)
2024-08-07 BIO Asia 2024 – Taiwan: Highlights and Event Recap
2024-08-06 Week 1, August 2024: ADCs: Funding Trends
2024-08-03 BIX (BIOPLUS INTERPHEX KOREA): Technology Highlights
2024-07-30 Week 5, July 2024: ADCs & Gynecologic Cancer
2024-07-26 Antibody-Mediated Phagocytosis Against Cancer
2024-07-24 Antibody-Drug Conjugates: A Brief
2024-07-16 Week 3, July 2024: Immunostimulatory ADCs (iADCs)
2024-06-25 Week 4, June 2024: Immune Checkpoint Blockade
2024-06-19 Afucosylated Antibodies: Mechanism of Action and Therapeutic Applications
2024-06-17 Types of Payloads for Antibody-Drug Conjugates (ADCs)
2024-06-14 Multi-Payload Antibody–Drug Conjugates

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.